NL-OMON48636已完成2 期
*CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Hemorrhage: safety and proof-of-concept* - CLASH
niversitair Medisch Centrum Utrecht0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Confirmed aneurysmal subarachnoid hemorrhage (SAH)
- •2) Admission to either the UMCU or Erasmus MC within 11.5 hours after ictus
- •3) Age 18 years and older
排除标准
- •1) Life expectancy < 10 days;
- •2) Pregnant or breast-feeding women;
- •3) Participation in another clinical therapeutic study;
- •4) History of splenectomy or asplenia (potentially increased risk of
- •meningococcal infection);
- •5) Hematologic malignancy;
- •6) Patients receiving chemotherapy;
- •7) Patients who will undergo or underwent an organ transplantation;
- •8) Patients with myasthenia gravis, glucose-6-phosphate dehydrogenase
- •(G6PD) deficiency, or tuberculosis;
- •9) Patients who are or will be treated by plasmapheresis or
- •hemodialysis;
- •10) Patient with a creatinine clearance of <30 or serum creatinine levels
- •of >169 µmol/l
- •11) Patients with a known hereditary complement deficiency;
- •12) Patients allergic to eculizumab, proteins derived from mouse
- •products or other monoclonal antibodies;
- •13) Patients allergic to (prophylactic) antibiotic treatment for Neisseria
- •meningitidis (quinolones or ceftriaxone (therapeutic));
- •14) If on admission, it is likely that the aneurysm can only be treated
- •with extracranial-intracranial bypass surgery;
- •15) If based on head imaging, it will be unlikely that CSF can be obtained
- •48-72 hours after ictus;
- •16) Patients with an ongoing infection on admission which is not
- •appropriately treated;
- •17) Patients who were treated >4 times with antibiotics during the last
- •18) Patients on immunosuppressive therapy.
研究者
相似试验
进行中（未招募）
1 期
Inflammation inhibitors to reduce brain injury after a hemorrhagic stroke.Aneurysmal subarachnoid hemorrhageMedDRA version: 20.1Level: LLTClassification code 10042320Term: Subarachnoid hemorrhageSystem Organ Class: 100000004852EUCTR2017-004307-51-NLniversity Medical Center Utrecht40
尚未招募
不适用
Inflammation inhibitors to reduce brain injury after a hemorrhagic stroke.Subarachnoid hemorrhageNL-OMON22901niversity Medical Center Utrecht40
已完成
2 期
Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosisMotor neuron diseaseISRCTN38393880Instituto Cardiológico Banfield20
进行中（未招募）
不适用
Immunochemotherapy in primary central nervous system lymphoma with rituximab, HD-MTX, HD Ara-C, cyclophosphamide, ifosfamide, vincristine, vindesine, temozolomide,and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomide - NLG PCNSEUCTR2006-004772-12-FIordic lymphoma group70
进行中（未招募）
不适用
Immunochemotherapy in primary central nervous system lymphoma with Rituximab, HD-MTX, HD-Ara C, cyclophosphamide, ifosfamide, vincristine, vindesine, temozolomide and DepoCyte induction followed by maintenance treatment in elderly patients with temozolomide.ewly diagnosed Primary Central Nervous LymphomaEUCTR2006-004772-12-SEordic Lymphoma Group70